id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-P-0610-0010,FDA,FDA-2011-P-0610,Petition Approval/Denial from FDA/CDER,Other,Citizen Petition,2014-07-23T04:00:00Z,2014,7,2014-07-23T04:00:00Z,,2014-07-23T19:35:50Z,,0,0,09000064817da617
FDA-2011-P-0610-0009,FDA,FDA-2011-P-0610,Attachments A through E Perrigo v. FDA Supplement from AbbVie Inc. Hogan Lovells US LLP,Supporting & Related Material,Background Material,2014-06-12T04:00:00Z,2014,6,,,2014-06-12T21:59:07Z,,0,0,09000064817202ba
FDA-2011-P-0610-0008,FDA,FDA-2011-P-0610,Supplement from AbbVie Inc. Hogan Lovells US LLP,Other,Supplement (SUP),2014-06-12T04:00:00Z,2014,6,2014-06-12T04:00:00Z,,2014-06-12T21:55:08Z,,0,0,090000648171fc35
FDA-2011-P-0610-0005,FDA,FDA-2011-P-0610,AbbVie Inc. (Hogan Lovells) - Supplement,Other,Supplement (SUP),2013-12-23T05:00:00Z,2013,12,2013-12-23T05:00:00Z,,2013-12-23T17:55:57Z,,0,0,09000064814bb904
FDA-2011-P-0610-0004,FDA,FDA-2011-P-0610,"Hogan Lovells LLP (behalf of AbbVie, Inc.) - Citizen Petition Supplement",Supporting & Related Material,Background Material,2013-01-07T05:00:00Z,2013,1,,,2013-01-07T16:35:55Z,,0,0,090000648119c7f7
FDA-2011-P-0610-0003,FDA,FDA-2011-P-0610,"FDA/CDER Letter to Mayer Brown LLP, dated February 16, 2012",Other,Letter(s),2012-04-05T04:00:00Z,2012,4,2012-04-05T04:00:00Z,,2019-07-08T14:20:51Z,,0,0,0900006480fea041
FDA-2011-P-0610-0002,FDA,FDA-2011-P-0610,"Acknowledgement Letter to Abbott Laboratories (Mayer Brown, LLP)",Other,Acknowledgement Letter/Receipt,2011-09-01T04:00:00Z,2011,9,2011-09-01T04:00:00Z,,2022-08-03T14:26:02Z,,0,0,0900006480ee6771
FDA-2011-P-0610-0001,FDA,FDA-2011-P-0610,"Abbott Laboratories (Mayer Brown, LLP) - Citizen Petition",Other,Citizen Petition,2011-09-01T04:00:00Z,2011,9,2011-09-01T04:00:00Z,,2019-07-08T14:20:32Z,,0,0,0900006480ee676f